Mate-Kole C Charles, Conway James, Catayong Katherine, Bieu Rachel, Sackey Naa Amerley, Wood Rebecca, Fellows Robert
Department of Psychology, Central Connecticut State University, New Britain, CT 06050, USA.
Arch Phys Med Rehabil. 2009 Sep;90(9):1469-77. doi: 10.1016/j.apmr.2009.02.007.
To validate the revised version of the Quick Cognitive Screening Test (QCST).
Cross-sectional.
Senior homes; hospital; college campus.
Participants (N=377; 114 men, 263 women) were recruited comprising healthy controls (n=201; 40 men, 161 women), subjects with dementia (n=93; 34 men, 59 women) including Alzheimer disease (n=73) and vascular dementia (n=20); subjects with psychiatric illness (n=35, 15 men, 20 women), specifically schizophrenia or bipolar disorder; and subjects with other neurologic conditions (n=48, 25 men, 23 women) such as traumatic brain injury (n=12) and cerebrovascular disease (n=31). Diagnoses were confirmed by physicians using appropriate criteria. Recruitment was done in the northeastern region.
Not applicable.
In an effort to examine the reliability and validity of the revised QCST, participants were administered the revised QCST with a number of standardized measures (ie, Alzheimer's Disease Assessment Scale-Cognitive, Mini-Mental State Examination, Tests of Oral Fluency, Trail-Making Test, and Functional Activities Questionnaire).
The results revealed that the revised QCST discriminated between healthy controls and the neuropsychiatric participants. Additionally, the revised QCST significantly correlated with other standardized measures, confirming the revised QCST's reliability and validity as a screening instrument for subjects with cognitive deficits.
The revised QCST provides the clinician with a short yet reliable screening instrument in detecting cognitive deficits in subjects with dementia and other neurologic conditions.
验证快速认知筛查测试(QCST)修订版。
横断面研究。
养老院;医院;大学校园。
招募了参与者(N = 377;男性114名,女性263名),包括健康对照组(n = 201;男性40名,女性161名)、痴呆患者(n = 93;男性34名,女性59名),其中包括阿尔茨海默病(n = 73)和血管性痴呆(n = 20);精神疾病患者(n = 35,男性15名,女性20名),具体为精神分裂症或双相情感障碍;以及患有其他神经系统疾病的患者(n = 48,男性25名,女性23名),如创伤性脑损伤(n = 12)和脑血管疾病(n = 31)。诊断由医生根据适当标准确认。招募在东北地区进行。
不适用。
为检验修订版QCST的信度和效度,对参与者进行修订版QCST,并采用了一些标准化测量方法(即阿尔茨海默病评估量表 - 认知部分、简易精神状态检查表、口语流畅性测试、连线测验和功能活动问卷)。
结果显示,修订版QCST能够区分健康对照组和神经精神疾病参与者。此外,修订版QCST与其他标准化测量方法显著相关,证实了修订版QCST作为认知缺陷受试者筛查工具的信度和效度。
修订版QCST为临床医生提供了一种简短而可靠的筛查工具,用于检测痴呆和其他神经系统疾病患者的认知缺陷。